Research Articles
Updates about new sleep medicine research publications, funding opportunities, and NIH news

New class of sleep medication debuts in SLEEP 2012 presentation

Findings based on efficacy trials using suvorexant, a new class of sleep medications, to treat insomnia made a splash during a late-breaking abstract session Wednesday at SLEEP 2012, the 26th Annual Meeting of the Associated Professional Sleep Societies. Researchers and the drug manufacturer Merck report suvorexant significantly reduced the time it took for patients to fall asleep and increase the amount of time patients stayed asleep compared to a placebo.

2017-08-31T20:47:43-05:00June 13th, 2012|Professional Development, Research|

NIH announces Funding Opportunity for development of obesity interventions

The National Heart Lung and Blood Institute (NHLBI) and several other components of the NIH have issued a Funding Opportunity Announcement (FOA) for the development of obesity prevention programs. The FOA "Exploratory/Development Clinical Research Grants in Obesity (R21)" encourages grant applications from institutions that propose clinical studies that will accelerate the development of interventions for the prevention or treatment of overweight or obesity in adults and/or children. The open date for the funding opportunity is May 16.

2024-08-06T14:56:55-05:00May 10th, 2012|Research|

AHRQ seeks public commentary on report ‘Future Research Needs for Diagnosis of Obstructive Sleep Apnea’

The U.S. Department of Health and Human Services (HHS) Agency for Healthcare Research and Quality (AHRQ) is seeking public comment on its new draft report titled "Future Research Needs for Diagnosis of Obstructive Sleep Apnea." The intended purpose of the report is to help researchers and funders of research make well-informed decisions in designing and funding research related to obstructive sleep apnea. The deadline for commentary is March 6, 2012.

2024-08-05T14:17:01-05:00February 17th, 2012|Research|
Go to Top